PL2332556T3 - Drożdże do leczenia wrzodów żołądka lub jelit wywołanych przez środki gastrotoksyczne - Google Patents

Drożdże do leczenia wrzodów żołądka lub jelit wywołanych przez środki gastrotoksyczne

Info

Publication number
PL2332556T3
PL2332556T3 PL10194022T PL10194022T PL2332556T3 PL 2332556 T3 PL2332556 T3 PL 2332556T3 PL 10194022 T PL10194022 T PL 10194022T PL 10194022 T PL10194022 T PL 10194022T PL 2332556 T3 PL2332556 T3 PL 2332556T3
Authority
PL
Poland
Prior art keywords
gastrotoxic
yeasts
agents
treatment
gastrointestinal ulcers
Prior art date
Application number
PL10194022T
Other languages
English (en)
Inventor
Philippe Girard
Guern Marie-Emmanuelle Le
Marc Verleye
Bernard Hublot
Original Assignee
Biocodex
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocodex filed Critical Biocodex
Publication of PL2332556T3 publication Critical patent/PL2332556T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/16—Yeasts; Culture media therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Botany (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PL10194022T 2009-12-08 2010-12-07 Drożdże do leczenia wrzodów żołądka lub jelit wywołanych przez środki gastrotoksyczne PL2332556T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0958734A FR2953412B1 (fr) 2009-12-08 2009-12-08 Medicament pour le traitement des ulceres gastro-intestinaux
EP10194022.9A EP2332556B1 (fr) 2009-12-08 2010-12-07 Levures pour le traitement des ulcères gastriques ou intestinaux induits par des agents gastrotoxiques

Publications (1)

Publication Number Publication Date
PL2332556T3 true PL2332556T3 (pl) 2016-05-31

Family

ID=42301615

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10194022T PL2332556T3 (pl) 2009-12-08 2010-12-07 Drożdże do leczenia wrzodów żołądka lub jelit wywołanych przez środki gastrotoksyczne

Country Status (7)

Country Link
US (1) US9241961B2 (pl)
EP (1) EP2332556B1 (pl)
CA (1) CA2724937C (pl)
ES (1) ES2556340T3 (pl)
FR (1) FR2953412B1 (pl)
PL (1) PL2332556T3 (pl)
PT (1) PT2332556E (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111278326A (zh) 2017-07-28 2020-06-12 轨迹Ip有限责任公司 改善皮肤、头发和头皮健康的基于酵母的面膜
EP3801463A4 (en) 2018-05-25 2022-05-04 Locus IP Company, LLC THERAPEUTIC COMPOSITIONS FOR IMPROVED HEALING OF WOUNDS AND SCARS

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6649383B1 (en) * 2002-06-28 2003-11-18 Ultra Biotech Limited Dietary supplements beneficial for the gastrointestinal system
AU2003274355A1 (en) * 2002-10-24 2004-05-13 Micap Plc. Targeted delivery
US7799328B2 (en) * 2004-12-23 2010-09-21 Biocodex Method for treating weight loss in patients suffering from inflammatory bowel diseases
US20070298013A1 (en) * 2006-06-23 2007-12-27 Altman Jay A Animal Nutritional Supplement and Method

Also Published As

Publication number Publication date
FR2953412B1 (fr) 2012-04-20
EP2332556A1 (fr) 2011-06-15
CA2724937A1 (fr) 2011-06-08
FR2953412A1 (fr) 2011-06-10
PT2332556E (pt) 2016-01-22
CA2724937C (fr) 2020-05-26
ES2556340T3 (es) 2016-01-15
US9241961B2 (en) 2016-01-26
US20110135616A1 (en) 2011-06-09
EP2332556B1 (fr) 2015-09-16

Similar Documents

Publication Publication Date Title
FIC20250029I1 (fi) neratinibi
FIC20230025I1 (fi) neratinibi
SMT201500053B (it) 2-Amminobenzimidazol-5-carbossammidi come agenti nati-infiammatori
HUE041891T2 (hu) Berendezés ipari célokra használt víz kezelésére
LT2596786T (lt) Eikozapentaeno rūgšties etilo esterio naudojimas hipertriglicidemijai gydyti
IL225867B (en) Coelenterazine substrates
EP2518579A4 (en) ROBOT
UA22227S (uk) Пристрій для обробляння води
BR112013014943A2 (pt) compostos úteis para o tratamento de aids
EP2406266A4 (en) 7-CYCLOALKYLAMINOCHINOLONE AS GSK-3 HEMMER
PL2338519T3 (pl) Środek do leczenia zwłóknienia szpiku
DK2442771T3 (da) Silikone-arbehandlingspræparat
BR112013013519A2 (pt) wafer de ostomia
ZA201208172B (en) Methods for the treatment of il-1b related conditions
EP2413941A4 (en) Renin Inhibitors
PL3657798T3 (pl) Sposób dwupredykcyjnego dekodowania obrazu
DE112011103919A5 (de) Endoskop
BRPI1007543A2 (pt) tratamento de psoríase
EP2536436A4 (en) ANTIMIR-451 FOR THE TREATMENT OF POLYCYCLES
EP2556786A4 (en) Endoscope
EP2534302A4 (en) SURFACE TREATMENT COMPOSITION
EP2540739A4 (en) OLIGOPEPTIDE WITH OSTEOBLASTENDIFFERENZIERUNG
FI20096192A0 (fi) Kohteen valaiseminen
DE102010031245A8 (de) Substratbehandlungseinrichtung
FIU20090470U0 (fi) Aukirullain